William Blair analyst Brandon Vazquez has maintained their neutral stance on NVST stock, giving a Hold rating yesterday.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Brandon Vazquez has given his Hold rating due to a combination of factors related to Envista Holdings’ current market position and future prospects. The company’s management has demonstrated effective execution on key initiatives, such as commercial investments in implants and cost reductions in the clear aligners segment, which have contributed positively to their financial performance.
Despite these positive developments, the valuation of Envista’s shares, trading at 18 times the projected 2026 earnings per share, suggests that much of the anticipated benefits are already reflected in the current stock price. As a result, Vazquez believes that while the company is well-positioned to meet expectations, the potential for significant upside is limited, justifying a Hold rating.
According to TipRanks, Vazquez is an analyst with an average return of -0.4% and a 48.08% success rate. Vazquez covers the Healthcare sector, focusing on stocks such as PROCEPT BioRobotics, Neogen, and Intuitive Surgical.